Clearside Biomedical
CLSD
CLSD
86 hedge funds and large institutions have $218M invested in Clearside Biomedical in 2018 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more capital invested
Capital invested by funds: $211M → $218M (+$7.21M)
44% less call options, than puts
Call options by funds: $885K | Put options by funds: $1.57M
Holders
86
Holding in Top 10
–
Calls
$885K
Puts
$1.57M
Top Buyers
| 1 | +$8.72M | |
| 2 | +$6.9M | |
| 3 | +$4.25M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.14M |
| 5 |
Man Group
London,
United Kingdom
|
+$1.58M |
Top Sellers
| 1 | -$7.28M | |
| 2 | -$3.21M | |
| 3 | -$3.1M | |
| 4 |
Millennium Management
New York
|
-$1.62M |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.15M |